A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Phase 1/2 Unknown
260 enrolled
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Phase 1/2 Unknown
314 enrolled
Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors
Phase 1/2 Unknown
60 enrolled
Autologous Killer Cell Therapy in Colon Cancer Patients
Phase 1/2 Unknown
20 enrolled
A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors
Phase 1/2 Unknown
60 enrolled
The Effectiveness of High-dose Intravenous Vitamin c With Very Low Carbohydrate Diet for Terminal Colon Cancer Patients
Phase 1/2 Unknown
40 enrolled
CAROSELL
Phase 1/2 Unknown
55 enrolled
Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer(NK)Cells
Phase 1/2 Unknown
200 enrolled
Safety and Efficacy of Anlotinib in Combination With Irinotecan in Patients With Pretreated Advanced Colorectal Cancer
Phase 1/2 Unknown
42 enrolled
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
Phase 1/2 Unknown
160 enrolled
Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer
Phase 1/2 Unknown
75 enrolled
CARTEPC
Phase 1/2 Unknown
60 enrolled
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Phase 1/2 Unknown
50 enrolled
NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase 1/2 Unknown
Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
Phase 1/2 Unknown
Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan
Phase 1/2 Unknown
56 enrolled
ProtectiScope CS Intended for Diagnostic and Therapeutic Colonoscopy
Phase 1/2 Unknown
200 enrolled
Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
Phase 1/2 Unknown
63 enrolled
Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer
Phase 1/2 Unknown
70 enrolled